We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
A phase I-II study of everolimus (RAD001) in combination with imatinib in patients with imatinib-resistant gastrointestinal stromal tumors.
- Authors
Schöffski, P; Reichardt, P; Blay, J-Y; Dumez, H; Morgan, J A; Ray-Coquard, I; Hollaender, N; Jappe, A; Demetri, G D
- Abstract
Imatinib is standard therapy for advanced gastrointestinal stromal tumors (GIST), but most patients develop resistance. This phase I-II study assessed the safety and efficacy of co-administering everolimus with imatinib in imatinib-resistant GIST.
- Publication
Annals of oncology : official journal of the European Society for Medical Oncology, 2010, Vol 21, Issue 10, p1990
- ISSN
1569-8041
- Publication type
Journal Article
- DOI
10.1093/annonc/mdq076